Nabil Saba, MD

I am Professor of Hematology Medical Oncology, adjunct Professor of Otolaryngology and co-Director of the Head and Neck Cancer program at Emory University. I have worked on exploring novel therapeutic approaches in head and neck cancers, and published extensively in this field. I am a well-recognized international leader in the field of head and neck cancer clinical research especially in the area of EGFR targeting and immunotherapeutic applications. I served as the principal investigator of more than 50 interventional and translational clinical trials and am currently the national chair of two cooperative group clinical trials in the field of head and neck oncology under the ECOG-ACRIN group. I am also an elected member of the ASCO clinical guidelines committee and the HN guidelines committee. I have received competitive NIH funding investigating novel genomic approaches in HPV related and unrelated OPCA and am the recipient of intramural funding studying this disease. As a result of my leadership role I have been elected chair of the recurrent metastatic as well as rare tumor Task Forces of the Head and Neck Cancer NCI steering committee. I have more than 150 peer reviewed manuscripts and textbook chapter publications, and am the editor of a textbook updating the management of esophageal cancer. I served as MPI on the Emory HNC SPORE grant submitted in 2020.

Disclosures: